Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with No hysterectomy in patients with a (Clinical and Radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer

Oncologist

Volumn 17, Issue 1, 2012, Pages 64-71

  Morice, Philippe ^a,m,n   Rouanet, Philippe ^b   Rey, Annie ^a   Romestaing, Pascale ^c   Houvenaeghel, Gilles ^d   Boulanger, Jean Charles ^e   Leveque, Jean ^f   Cowen, Didier ^g   Mathevet, Patrice ^h   Malhaire, Jean Pierre ⁱ   Magnin, Guillaume ^j   Fondrinier, Eric ^k   Berille, Jocelyne ^l   Haie Mederc, Christine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE VAL D AURELLE   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f CENTRE EUGÈNE MARQUIS   (France)

^g TIMONE HOSPITAL   (France)

^h EDOUARD HERRIOT HOSPITAL   (France)

ⁱ BREST UNIVERSITY HOSPITAL   (France)

^j POITIERS UNIVERSITY HOSPITAL   (France)

^k CENTRE PAUL PAPIN   (France)

^l FNCLCC   (France)

^m UNIVERSITÉ PARIS SACLAY   (France)

ⁿ INSERM   (France)

more..

Author keywords

Chemoradiation therapy; Locally advanced cervical cancer; Nodal involvement; Prognostic factors; Residual disease; Surgery; Survival

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RELAPSE; CANCER STAGING; CHEMORADIOTHERAPY; EVENT FREE SURVIVAL; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT RESPONSE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CHEMORADIOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84856266031     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0276     Document Type: Article

References (28)

1. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 2001;358:781-786.
2. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-5812.
3. Houvenaeghel G, Lelievre L, Gonzague-Casabianca L et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 2006;100:338-343.
4. Ferrandina G, Legge F, Fagotti A et al. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: Safety, outcome, and prognostic measures. Gynecol Oncol 2007;107(suppl 1): S127-S132.
5. Classe JM, Rauch P, Rodier JF et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: Morbidity and outcome: Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol 2006;102:523-529.
6. Azria E, Morice P, Haie-Meder C et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol 2005;12:332-337.
7. Darus CJ, Callahan MB, Nguyen QN et al. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma. Int J Gynecol Cancer 2008;18:730-735.
8. Colombo PE, Bertrand MM, GutowskiMet al. Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: Surgical morbidity and oncological results. Gynecol Oncol 2009;114:404-409.
9. Huguet F, Cojocariu OM, Levy P et al. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Int J Radiat Oncol Biol Phys 2008;72:1508-1515.
10. Ota T, Takeshima N, Tabata T et al. Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy. Br J Cancer 2008;99:1216-1220.
11. Morice P, Uzan C, Zafrani Y et al. The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer. Gynecol Oncol 2007;107(suppl 1):S122-S124.
12. International Federation of Gynecology and Obstetrics. Modifications in the staging for stage I vulvar and stage I cervical cancer. Int J Gynaecol Obstet 1995;50:215-216.
13. Leblanc E, Narducci F, Frumovitz M et al. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol 2007;105:304-311.
14. Michel G, Morice P, Castaigne D et al. Lymphatic spread in stage IB and II cervical carcinoma: Anatomy and surgical implications. Obstet Gynecol 1998;91:360-363.
15. International Commission on Radiation Units and Measurements (ICRU). ICRU Report 38: Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology. Report No. 38. Bethesda, MD: ICRU, 1985.
16. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272.
17. Chassagne D, Sismondi P, Horiot JC et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 1993;26: 195-202.
18. Keys HM, Bundy BN, Stehman FB et al.; Gynecologic Oncology Group. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: A randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 2003;89:343-353.
19. Touboul C, Uzan C, Mauguen A et al. Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. The Oncologist 2010;15:405-415.
20. Houvenaeghel G, Lelievre L, ButtarelliMet al. Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol 2007;33:498-503.
21. Vincens E, Balleyguier C, ReyAet al. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy: Correlation of radiologic findings with surgicopathologic results. Cancer 2008;113:2158-2165.
22. Pötter R, Haie-Meder C, Van Limbergen E et al.; GEC ESTRO Working Group. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67-77.
23. Chargari C, Magné N, Dumas I et al. Physics contributions and clinical outcome with 3D-MRIbased pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 2009;74:133-139.
24. Delpech Y, Haie-Meder C, Rey A et al. Paraaortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Ann Surg Oncol 2007;14:3223-3231.
25. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001;19:3745-3749.
26. Wright JD, Dehdashti F, Herzog TJ et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 2005;104:2484-2491.
27. Boughanim M, Leboulleux S, Rey A et al. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol 2008;26:2558-2561.
28. Mortier DG, Stroobants S, Amant F et al. Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB. Int J Gynecol Cancer 2008;18:723-729.